EASD 2024: Innovent shows off mazdutide’s efficacy in diabetes and obesity
The data from two Phase III trials demonstrated GLP-1/glucagon agonist’s efficacy in reducing blood glucose and weight.
Eupraxia reports positive data from eosinophilic esophagitis treatment trial
CVRx touts positive two-year data for heart failure neuromodulation device
Sanofi’s Phase III CSU treatment trial meets endpoints
How the Covid-19 pandemic will help researchers with the mpox emergency
EASD 2024: A COMBINEd approach for better diabetes management
GSK’s Phase I/II herpes simplex vaccine trial misses primary endpoint
Viridian Therapeutics’ stock jumps after Phase III trial met all endpoints
Analysis
View More
Themes
View MoreAlio starts trial to expand label for remote monitoring device
The CAVA study is expected to validate the use of SmartPatch technology.
More themes
Data Insights
View MoreLeading innovators with viral vectors for the pharmaceutical industry
The pharmaceutical industry continues to be a hotbed of innovation, with activity driven by the evolution of new treatment paradigms,...
Discover Data Insights powered by our proprietary data
Understand the themes driving your sector, keep up with key innovation areas and track the activities of leading companies
More Insights
Buyer's Guides
View More
GlobalData Reports
View More
Digital Magazine
View MorePharma Technology Focus Magazine
Pharma Technology Focus is our digital magazine, free to read online on all devices. Click the magazine cover to read the latest issue. You can subscribe for free to have each new issue delivered to your inbox.
Testosterone could influence men’s immune response to Covid-19
AstraZeneca eyes up transition to eco-friendly inhaler propellant
As mpox spreads, ‘national governments have a moral responsibility to help’
Ultromics’s EchoGo misses primary endpoint in heart disease trial